Research progress in liver tissue engineering.

Area of Science:

• Regenerative Medicine
• Biomedical Engineering
• Hepatology

Background:

• Liver transplantation is the primary treatment for end-stage liver diseases (ESLD).
• A significant shortage of liver donors limits transplantation accessibility.
• Liver tissue engineering presents a promising alternative to address donor scarcity.

Purpose of the Study:

• To review recent advancements in liver tissue engineering.
• To highlight the critical components: cell sources, scaffolds, and bioreactors.
• To identify the gap between research progress and clinical application.

Main Methods:

• Review of current literature on cell sources for liver tissue engineering (hepatocytes, cell lines, stem cells).
• Analysis of scaffold requirements (biocompatibility, microstructure, degradation) and types (decellularized livers, collagens, plastics).
• Examination of bioreactor roles in providing essential microenvironments (oxygen, nutrients, growth factors).

Main Results:

• Various cell sources show potential for liver regeneration.
• Scaffolds must possess specific characteristics for optimal cell function.
• Bioreactors are crucial for mimicking in vivo conditions to support cell development.
• Significant progress has been made in all three key areas of liver tissue engineering.

Conclusions:

• Liver tissue engineering requires careful consideration of cell sources, scaffolds, and bioreactors.
• Despite advancements, a gap persists between research and practical application.
• Further development is needed to translate tissue-engineered livers into clinical practice.